Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023

Hiroshi Karasawa, Hirokuni Mizoguchi, Bryan Choi, Chia-Ling Hsieh, Masaaki Miyano, Yuu Moriya, Sasikumar Muthusamy, Koji Takakura, Kunihiko Suzuki, Yoshie Tsurumaki, Takeshi Watanabe, Karen Wen, Tomohiro Yoneda, Ta-Tung Yuan, Masayuki Nomura

Open source

DOI: 10.1016/j.reth.2024.09.015
Published: 2024-06
Container: Regenerative Therapy
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.reth.2024.09.015,
  title = {Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023},
  author = {Hiroshi Karasawa and Hirokuni Mizoguchi and Bryan Choi and Chia-Ling Hsieh and Masaaki Miyano and Yuu Moriya and Sasikumar Muthusamy and Koji Takakura and Kunihiko Suzuki and Yoshie Tsurumaki and Takeshi Watanabe and Karen Wen and Tomohiro Yoneda and Ta-Tung Yuan and Masayuki Nomura},
  year = {2024},
  journal = {Regenerative Therapy},
  doi = {10.1016/j.reth.2024.09.015},
  url = {https://doi.org/10.1016/j.reth.2024.09.015}
}

RIS

TY  - JOUR
TI  - Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023
AU  - Hiroshi Karasawa
AU  - Hirokuni Mizoguchi
AU  - Bryan Choi
AU  - Chia-Ling Hsieh
AU  - Masaaki Miyano
AU  - Yuu Moriya
AU  - Sasikumar Muthusamy
AU  - Koji Takakura
AU  - Kunihiko Suzuki
AU  - Yoshie Tsurumaki
AU  - Takeshi Watanabe
AU  - Karen Wen
AU  - Tomohiro Yoneda
AU  - Ta-Tung Yuan
AU  - Masayuki Nomura
PY  - 2024
JO  - Regenerative Therapy
DO  - 10.1016/j.reth.2024.09.015
UR  - https://doi.org/10.1016/j.reth.2024.09.015
ER  -

APA

Karasawa, H., Mizoguchi, H., Choi, B., Hsieh, C., Miyano, M., Moriya, Y., Muthusamy, S., Takakura, K., Suzuki, K., Tsurumaki, Y., Watanabe, T., Wen, K., Yoneda, T., Yuan, T., & Nomura, M. (2024). Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023. Regenerative Therapy. https://doi.org/10.1016/j.reth.2024.09.015

Source records

crossref · retrieved 2026-09-27T05:22:47.996Z